The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Maria Alonso ...
The state of pharma’s chief marketing officers part 2: Being an ‘innovation catalyst’ for creativity
In the not too distant past, pharma lagged behind consumer advertising’s ability to churn out cutting-edge creativity. Weighed down by the regulatory, safety and compliance aspects that are par for ...
Rebecca Willumson (Publisher, Fierce Pharma): Pharma marketing seems to be evolving faster than ever. What are some of the most urgent conversations you’re hearing from brand and digital leaders right ...
The digital marketing landscape is rapidly changing, as is the creative use of tools and mediums required for successful digital marketing campaigns. This is particularly true in the heavily regulated ...
Pharma marketing is shifting from a product-centered approach to one driven by data and engagement, according to Kamya Elawadhi, chief client officer at Doceree. In an interview with Fierce Pharma ...
As a relatively new role in pharma — and one that not all pharma companies have — chief marketing officers (CMOs) are tasked with raising the profile of marketing within their companies and driving ...
OptimizeRx Corporation is evolving from an EHR messaging platform to a clinical data and AI-driven advertising company, leveraging DAAP and MNT technologies. Q2 2025 financials show strong revenue ...
This article is also available in Spanish. Please use the toggle above the headline to switch languages. Visit digiday.com/es to read more content in Spanish. Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results